Crop Life Science Past Earnings Performance
Past criteria checks 2/6
Crop Life Science has been growing earnings at an average annual rate of 15%, while the Chemicals industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 38.5% per year. Crop Life Science's return on equity is 6.9%, and it has net margins of 2.6%.
Key information
15.0%
Earnings growth rate
10.4%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 38.5% |
| Return on equity | 6.9% |
| Net Margin | 2.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Crop Life Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,066 | 55 | 115 | 0 |
| 30 Jun 24 | 2,026 | 57 | 114 | 0 |
| 31 Mar 24 | 1,986 | 60 | 113 | 0 |
| 31 Dec 23 | 1,739 | 63 | 112 | 0 |
| 30 Sep 23 | 1,492 | 65 | 111 | 0 |
| 30 Jun 23 | 1,402 | 53 | 112 | 0 |
| 31 Mar 23 | 1,312 | 41 | 113 | 0 |
| 28 Feb 23 | 1,337 | 48 | 129 | 0 |
| 31 Mar 22 | 1,020 | 28 | 136 | 0 |
| 31 Mar 21 | 1,189 | 37 | 139 | 0 |
| 31 Mar 20 | 1,351 | 32 | 121 | 0 |
Quality Earnings: CLSL has high quality earnings.
Growing Profit Margin: CLSL's current net profit margins (2.6%) are lower than last year (4.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLSL's earnings have grown by 15% per year over the past 5 years.
Accelerating Growth: CLSL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CLSL had negative earnings growth (-15.9%) over the past year, making it difficult to compare to the Chemicals industry average (7.3%).
Return on Equity
High ROE: CLSL's Return on Equity (6.9%) is considered low.